Content related to Faculty Spotlight: Juliet Emamaullee, MD, PhD

Study finds that T-cells expressing PD-1 may help predict recovery in children with acute liver failure.

CHLA researchers use imaging mass cytometry analysis of biopsies to find potential biomarkers that can predict transplant rejection.

Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first

Children’s Hospital Los Angeles researchers develop app to predict if children with acute liver failure will need an urgent liver transplant or can recover on their own.

A new class of drugs can relieve itching for cholestatic childhood liver disease and potentially lengthen time until a liver transplant is necessary.

After enduring years of severe abdominal pain, a teenager becomes the first pediatric patient in Southern California to undergo a rare procedure called TPIAT.

As a Bioinformatics Specialist in CHLA’s Spatial Biology and Genomics Core, Dr. Ding helps to extract the meaning out of “noisy” biological data.

Diagnosed with hepatoblastoma at 17 months old, Aaroh is thriving thanks to chemotherapy and a liver transplant—and the experts at Children’s Hospital Los Angeles who gave him life.